Scientific Evidence of the Therapeutic Effects of Dead Sea Treatments: A Systematic Review

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 2, 2012, Pages 186-200

  Katz, Uriel ^a   Shoenfeld, Yehuda ^b   Zakin, Varda ^c   Sherer, Yaniv ^d   Sukenik, Shaul ^e  

^a MACCABI HEALTHCARE SERVICES   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c VOLCANI CENTER   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^e BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

SEA WATER;

ACTINIC KERATOSIS; ANKYLOSING SPONDYLITIS; BALNEOTHERAPY; CLINICAL EFFECTIVENESS; DEEP SEA; ELECTROLYTE DISTURBANCE; EVIDENCE BASED MEDICINE; FIBROMYALGIA; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; KNEE OSTEOARTHRITIS; MUD THERAPY; OUTCOME ASSESSMENT; PATIENT SAFETY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SKIN DEFECT; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT DURATION; TREATMENT PLANNING; ULTRAVIOLET RADIATION;

EID: 84866488954     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.02.006     Document Type: Article

References (92)

1. Schamberg I.L. Treatment of psoriasis at the Dead Sea. Int J Dermatol 1978, 17(6):524-525.
2. Even-Paz Z., Shani J. The dead sea and psoriasis. Historical and geographic background. Int J Dermatol 1989, 28(1):1-9.
3. Sukenik S., Flusser D., Codish S., Abu-Shakra M. [The Dead Sea-a unique resort for patients suffering from joint diseases]. Harefuah 2010, 149(3):175-179. 93.
4. David M., Efron D., Hodak E., Even-Paz Z. Treatment of psoriasis at the Dead Sea: Why, how and when?. Isr Med Assoc J 2000, 2(3):232-234.
5. Kudish A.I., Abels D., Harari M. Ultraviolet radiation properties as applied to photoclimatherapy at the Dead Sea. Int J Dermatol 2003, 42(5):359-365.
6. Ma'Or Z., Yehuda S., Voss W. Skin smoothing effects of Dead Sea minerals: comparative profilometric evaluation of skin surface. Intl J Cosmet Sci 1997, 19(3):105-110.
7. Riyaz N., Arakkal F.R. Spa therapy in dermatology. Indian J Dermatol Venereol Leprol 2011, 77(2):128-134.
8. Dostrovsky A., Sagher F. Preliminary report; the therapeutic effect of the hot springs of Zohar (Dead Sea) on some skin diseases. Harefuah 1959, 57:143-145.
9. Hunt S.A., Baker D.W., Chin M.H., Cinquegrani M.P., Feldman A.M., Francis G.S., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure): Developed in collaboration with the international society for heart and lung transplantation; endorsed by the heart failure society of America. Circulation 2001, 104(24):2996-3007.
10. Matz H., Orion E., Wolf R. Balneotherapy in dermatology. Dermatol Ther 2003, 16(2):132-140.
11. Halverstam C.P., Lebwohl M. Nonstandard and off-label therapies for psoriasis. Clin Dermatol 2008, 26(5):546-553.
12. Kazandjieva J., Grozdev I., Darlenski R., Tsankov N. Climatotherapy of psoriasis. Clin Dermatol 2008, 26(5):477-485.
13. Abels D.J., Rose T., Bearman J.E. Treatment of psoriasis at a Dead Sea dermatology clinic. Int J Dermatol 1995, 34(2):134-137.
14. Knudsen E.A., Worm A.M. [Psoriasis treatment at the Dead Sea]. Ugeskr Laeger 1996, 158(45):6440-6443.
15. Klein A., Schiffner R., Schiffner-Rohe J., Einsele-Krämer B., Heinlin J., Stolz W., et al. A randomized clinical trial in psoriasis: Synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). J Eur Acad Dermatol Venereol 2011, 25(5):570-578.
16. Dawe R.S., Yule S., Cameron H., Moseley H., Ibbotson S.H., Ferguson J. A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br J Dermatol 2005, 153(3):613-619.
17. Schiffner R., Schiffner-Rohe J., Wölfl G., Landthaler M., Glässl A., Walther T., et al. Evaluation of a multicentre study of synchronous application of narrowband ultraviolet B phototherapy (TL-01) and bathing in Dead Sea salt solution for psoriasis vulgaris. Br J Dermatol 2000, 142(4):740-747.
18. Holló P., Gonzalez R., Kása M.M., Horváth A. Synchronous balneophototherapy is effective for the different clinical types of psoriasis. J Eur Acad Dermatol Venereol 2005, 19(5):578-581.
19. Roos S., Hammes S., Ockenfels H.M. [Psoriasis. Natural versus Artificial balneophototherapy.]. Hautarzt 2010, 61(8):683-690.
20. Harari M., Shani J. Demographic evaluation of successful antipsoriatic climatotherapy at the Dead Sea (Israel) DMZ Clinic. Int J Dermatol 1997, 36(4):304-308.
21. Harari M., Czarnowicki T., Fluss R., Ruzicka TandIngber A. Patients with early-onset psoriasis achieve better results following Dead Sea climatotherapy. J Eur Acad Dermatol Venereol 2011, [Epub ahead of print].
22. Cohen A.D., Shapiro J., Michael D., Hodak E., Van-Dijk D., Naggan L., et al. Outcome of "short-term" Dead Sea climatotherapy for psoriasis. Acta Derm Venereol 2008, 88(1):90-91.
23. Harari M., Novack L., Barth J., David M., Friger M., Moses S.W. The percentage of patients achieving PASI 75 after 1 month and remission time after climatotherapy at the Dead Sea. Int J Dermatol 2007, 46(10):1087-1091.
24. Schempp C.M., Blumke C., Schulte-Monting J., Schopf E., Simon J.C. [Effect of various salt solutions on ultraviolet B-induced erythema and pigmentation]. Hautarzt 1998, 49(6):482-486.
25. Boer J., Schothorst A.A., Boom B., Hermans J., Suurmond D. Influence of water and salt solutions on UVB irradiation of normal skin and psoriasis. Arch Dermatol Res 1982, 273(3-4):247-259.
26. Shiri J., Amichai B., Grunwald M.H. Re-climatotherapy: A combination of acitretin and climatotherapy at the Dead Sea. J Am Acad Dermatol 2005, 52(3 Pt 1):541-542.
27. Ben-Amitai D., David M. Climatotherapy at the dead sea for pediatric-onset psoriasis vulgaris. Pediatr Dermatol 2009, 26(1):103-104.
28. Hodak E., Gottlieb A.B., Segal T., Politi Y., Maron L., Sulkes J., et al. Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: Combined effects on epidermal and immunologic activation. J Am Acad Dermatol 2003, 49(3):451-457.
29. Gruner S., Zwirner A., Boonen H., Sönnichsen N. [Effect of treatment with salt from the Dead Sea (Tomesa therapy) on epidermal Langerhans cells-a clinical study]. Z Hautkr 1990, 65(12):1146-1151.
30. Halevy S., Giryes H., Friger M., Grossman N., Karpas Z., Sarov B., et al. The role of trace elements in psoriatic patients undergoing balneotherapy with Dead Sea bath salt. Isr Med Assoc J 2001, 3(11):828-832.
31. Shani J., Sharon R., Koren RandEven-Paz Z. Effect of dead-sea brine and its main salts on cell growth in culture. Pharmacologist 1987, 35(6):339-347.
32. Levi-Schaffer F., Shani J., Politi Y., Rubinchik EandBrenner S. Inhibition of proliferation of psoriatic and healthy fibroblasts in cell culture by selected dead-sea salts. Pharmacologist 1996, 52(5):321-328.
33. Nissen J.B., Avrach W.W., Hansen E.S., Stengaard-Pedersen K., Kragballe K. Increased levels of enkephalin following natural sunlight (combined with salt water bathing at the Dead Sea) and ultraviolet A irradiation. Br J Dermatol 1998, 139(6):1012-1019.
34. Shani J., Livshitz T., Robberecht H., Van Grieken R., Rubinstein N., Even-Paz Z. Increased erythrocyte glutathione peroxidase activity in psoriatics consuming high-selenium drinking water at the Dead-Sea Psoriasis Treatment Center. Pharmacol Res Commun 1985, 17(5):479-488.
35. Shani J., Barak S., Ram M., Levi D., Pfeifer Y., Schlesinger T., et al. Serum bromine levels in psoriasis. Pharmacologist 1982, 25(6):297-307.
36. Abels D.J., Kattan-Byron J. Psoriasis treatment at the Dead Sea: A natural selective ultraviolet phototherapy. J Am Acad Dermatol 1985, 12(4):639-643.
37. Kushelevsky A.P., Kudish A.I. Intercomparison of global, ultraviolet B and A radiation measurements in the Dead Sea region (ein Bokek) and Be'er Sheva, Israel. J Med Sciences 1996, 32(Suppl):S24-S27.
38. Even-Paz Z., Efron D. Determination of solar ultraviolet dose in the Dead Sea treatment of psoriasis. Isr Med Assoc J 2003, 5(2):87-88.
39. Kudish A.I., Harari M., Evseev E.G. The measurement and analysis of normal incidence solar UVB radiation and its application to the photoclimatherapy protocol for psoriasis at the Dead Sea, Israel. Photochem Photobiol 2011, 87(1):215-222.
40. Shani J., Harari M., Hristakieva E., Seidl V., Bar-Giyora J. Dead-sea climatotherapy versus other modalities of treatment for psoriasis: Comparative cost-effectiveness. Int J Dermatol 1999, 38(4):252-262.
41. Weinrauch L. The cost of psoriasis treatment at the Dead Sea. Int J Dermatol 1996, 35(2):150-151.
42. Gambichler T., Altmeyer P., Hoffmann K. Cost-effectiveness of dead-sea climatotherapy and balneophototherapy of psoriasis. Int J Dermatol 2001, 40(2):158-159.
43. Sukenik S., Neumann L., Flusser D., Kleiner-Baumgarten A., Buskila D. Balneotherapy for rheumatoid arthritis at the Dead Sea. Isr J Med Sci 1995, 31(4):210-214.
44. Sukenik S., Buskila D., Neumann L. Mud pack therapy in rheumatoid arthritis. Clin Rheumatol 1992, 11(2):243-247.
45. Sukenik S., Neumann L., Buskila D., Kleiner-Baumgarten A., Zimlichman J.S., Horowitz J. Dead Sea bath salts for the treatment of rheumatoid arthritis. Clin Exp Rheumatol 1990, 8(4):353-357.
46. Codish S., Abu-Shakra M., Flusser D., Friger M., Sukenik S. Mud compress therapy for the hands of patients with rheumatoid arthritis. Rheumatol Int 2005, 25(1):49-54.
47. Sukenik S., Buskila D., Neumann L., Kleiner-Baumgarten A., Zimlichman S., Horowitz J. Sulphur bath and mud pack treatment for rheumatoid arthritis at the Dead Sea area. Ann Rheum Dis 1990, 49(2):99-102.
48. Sukenik S., Giryes H., Halevy S., Neumann L., Flusser D., Buskila D. Treatment of psoriatic arthritis at the Dead Sea. J Rheumatol 1994, 21(7):1305-1309.
49. Elkayam O., Ophir J., Brener S., Paran D., Wigler I., Efron D., et al. Immediate and delayed effects of treatment at the Dead Sea in patients with psoriatic arthritis. Rheumatol Int 2000, 19(3):77-82.
50. Sukenik S., Baradin R., Codish S., Neumann L., Flusser D., Abu-Shakra M., et al. Balneotherapy at the Dead Sea area for patients with psoriatic arthritis and concomitant fibromyalgia. Isr Med Assoc J 2001, 3(2):147-150.
51. Buskila D., Abu-Shakra M., Neumann L., Odes L., Shneider E., Flusser D., et al. Balneotherapy for fibromyalgia at the Dead Sea. Rheumatol Int 2001, 20(3):105-108.
52. Neumann L., Sukenik S., Bolotin A., Abu-Shakra M., Amir M., Flusser D., et al. The effect of balneotherapy at the Dead Sea on the quality of life of patients with fibromyalgia syndrome. Clin Rheumatol 2001, 20(1):15-19.
53. Avriel A., Fuchs L., Plakht Y., Cicurel A., Apfelbaum A., Satran R., et al. Quality of life at the Dead Sea region: The lower the better?. An observational study. Health Qual Life Outcomes 2011, 9:38.
54. Codish S., Dobrovinsky S., Abu Shakra M., Flusser D., Sukenik S. Spa therapy for ankylosing spondylitis at the Dead Sea. Isr Med Assoc J 2005, 7(7):443-446.
55. Sukenik S., Flusser D., Codish S., Abu-Shakra M. Balneotherapy at the dead sea area for knee osteoarthritis. Isr Med Assoc J 1999, 1(2):83-85.
56. Flusser D., Abu-Shakra M., Friger M., Codish S., Sukenik S. Therapy with mud compresses for knee osteoarthritis: Comparison of natural mud preparations with mineral-depleted mud. J Clin Rheumatol 2002, 8(4):197-203.
57. Sukenik S., Mayo A., Neumann L., Flusser D., Kleiner-Baumgarten A., Buskila D. [Dead Sea bath salts for osteoarthritis of the knee]. Harefuah 1995, 129(3-4):100-103. 158.
58. Sherman G., Zeller L., Avriel A., Friger M., Harari M., Sukenik S. Intermittent balneotherapy at the Dead Sea area for patients with knee osteoarthritis. Isr Med Assoc J 2009, 11(2):88-93.
59. Sanmartin C., Plano D., Font M., Palop J.A. Selenium and clinical trials: New therapeutic evidence for multiple diseases. Curr Med Chem 2011, 18(30):4635-4650.
60. Huang Z., Rose A.H., Hoffmann P.R. The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2012, 16(7):705-743.
61. Nielsen F.H. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 2010, 68(6):333-340.
62. Harari M., Dramsdahl E., Shany S., Baumfeld Y., Ingber A., Novack V., et al. Increased vitamin D serum levels correlate with clinical improvement of rheumatic diseases after Dead Sea climatotherapy. Isr Med Assoc J 2011, 13(4):212-215.
63. Are they safe to use for cooking?. Mayo Clin Health Lett 2010, 28(12):8. I'm hearing a lot about Dead Sea salts.
64. Kushelevsky A.M.A. Ultraviolet measurements at the Dead Sea and at Beersheba, Israel. J Med Sci 1975, 11(5):488-490.
65. Kushelevsky A.P., Harari M., Kudish A.I., Hristakieva E., Ingber A., Shani J. Safety of solar phototherapy at the Dead Sea. J Am Acad Dermatol 1998, 38(3):447-452.
66. David M., Tsukrov B., Adler B., Hershko K., Pavlotski F., Rozenman D., et al. Actinic damage among patients with psoriasis treated by climatotherapy at the Dead Sea. J Am Acad Dermatol 2005, 52(3 Pt 1):445-450.
67. Paltiel O., Adler B., Herschko K., Tsukrov B., David M. Are patients with psoriasis susceptible to the classic risk factors for actinic keratoses?. Arch Dermatol 2004, 140(7):805-810.
68. Frentz G., Olsen J.H., Avrach W.W. Malignant tumours and psoriasis: climatotherapy at the Dead Sea. Br J Dermatol 1999, 141(6):1088-1091.
69. Ish-Shalom N., Better O.S. Volume regulation in man during neck-out immersion in a medium with high specific gravity (Dead Sea water). Isr J Med Sci 1984, 20(2):109-112.
70. Bernheim J., Saidi J., Kovatz S., Solan H. Decrease in blood pressure in the Dead Sea region. Isr J Med Sci 1984, 20(12):1193-1194.
71. Gabizon I., Shiyovich A., Novack V., Khalameizer V., Yosefy C., Moses S.W., et al. Impact of descent and stay at a Dead Sea resort (low altitude) on patients with systolic congestive heart failure and an implantable cardioverter defibrillator. Isr Med Assoc J 2011, 13(7):402-407.
72. Paran E., Neuman L., Sukenik S. Blood pressure changes at the Dead Sea (a low altitude area). J Hum Hypertens 1998, 12(8):551-555.
73. Kushelevsky A.P., Harari M., Hristakieva E., Shani J. Climatotherapy of psoriasis and hypertension in elderly patients at the dead-sea. Pharmacol Res Off J Ital Pharmacol Soc'Y 1996, 34(1-2):87-91.
74. Shani J., Kushelevsky A.P., Harari M., Even-Paz Z. Sustained decrease of blood pressure in psoriatic patients during treatment at the Dead Sea. Pharmacol Res 1995, 31(6):355-359.
75. Taylor B.R., Sosa R., Stone W.J. Bromide toxicity from consumption of dead sea salt. Am J Med 2010, 123(3):e11-e12.
76. Abdel-Fattah A., Pingitore N.E. Low levels of toxic elements in Dead Sea black mud and mud-derived cosmetic products. Environ Geochem Health 2009, 31(4):487-492.
77. Mueller B., Stadelmann R., Christ E., Diem P. The 'dead-sea thyrotoxicosis': A side-effect of the dead-sea climatotherapy?. Eur J Dermatol EJD 2003, 13(4):416-417. Author reply 416.
78. Mosseri M., Porath A., Ovsyshcher I., Stone D. Electrocardiographic manifestations of combined hypercalcemia and hypermagnesemia. J Electrocardiol 1990, 23(3):235-241.
79. Oren S., Rapoport J., Zlotnik M., Brami J.L., Heimer D., Chaimovitz C., Chaimovitz C. Extreme hypermagnesemia due to ingestion of Dead Sea water. Nephron 1987, 47(3):199-201.
80. Porath A., Mosseri M., Harman I., Ovsyshcher I., Keynan A. Dead Sea water poisoning. Ann Emerg Med 1989, 18(2):187-191.
81. Karadsheh N.S., Khraisha S. Comparative study of the levels of antioxidants of students at Amman and Dead Sea level. Aviat Space Environ Med 1993, 64(12):1125-1127.
82. Freeman A.K., Linowski G.J., Brady C., Lind L., Vanveldhuisen P., Singer G., et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003, 48(4):564-568.
83. Stern R.S. Psoralen and ultraviolet a light therapy for psoriasis. N Engl J Med 2007, 357(7):682-690.
84. Tanew A., Guggenbichler A., Hönigsmann H., Geiger J.M., Fritsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: A randomized, double-blind comparison study. J Am Acad Dermatol 1991, 25(4):682-684.
85. Boehncke W.H., Prinz J., Gottlieb A.B. Biologic therapies for psoriasis. A systematic review. J Rheumatol 2006, 33(7):1447-1451.
86. Gaujoux-Viala C., Smolen J.S., Landewé R., Dougados M., Kvien T.K., Mola E.M., et al. Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2010, 69(6):1004-1009.
87. Nam J.L., Winthrop K.L., van Vollenhoven R.F., Pavelka K., Valesini G., Hensor E.M., et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 2010, 69(6):976-986.
88. Heiberg M.S., Kaufmann C., Rødevand E., Mikkelsen K., Koldingsnes W., Mowinckel P., et al. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 Month results from a longitudinal, observational, multicentre study. Ann Rheum Dis 2007, 66(8):1038-1042.
89. Häuser W., Petzke F., Uceyler N., Sommer C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: A systematic review with meta-analysis. Rheumatology (Oxford) 2011, 50(3):532-543.
90. Hauser W., Petzke F., Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 2010, 11(6):505-521.
91. McLeod C., Bagust A., Boland A., Dagenais P., Dickson R., Dundar Y., et al. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: A systematic review and economic evaluation. Health Technol Assess 2007, 11(28):1-158. iii-iv.
92. Towheed T.E., Maxwell L., Judd M.G., Catton M., Hochberg M. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006, 1. CD004257.